probablybots
commited on
Commit
•
5c5bb95
1
Parent(s):
1061e0d
Update README.md
Browse files
README.md
CHANGED
@@ -1,3 +1,6 @@
|
|
|
|
|
|
|
|
1 |
# AIDO.RNA-1.6B
|
2 |
|
3 |
AIDO.RNA-1.6B is a general-purpose RNA foundation model with 1.6 billion parameters, trained on 42 million non-coding RNA sequences at single-nucleotide resolution. It achieves state-of-the-art performance on a comprehensive set of tasks, including RNA secondary structure prediction, mRNA-related tasks, RNA function prediction, and RNA inverse folding. After domain adaptation, AIDO.RNA excels in modeling protein-level tasks, highlighting its potential to leverage the central dogma for enhancing biomolecular representations. For more detailed information, please refer to [our paper](https://www.biorxiv.org/content/10.1101/2024.11.28.625345v1).
|
@@ -98,4 +101,4 @@ Please cite AIDO.RNA using the following BibTeX code:
|
|
98 |
year = {2024},
|
99 |
booktitle = {NeurIPS 2024 Workshop on AI for New Drug Modalities},
|
100 |
}
|
101 |
-
```
|
|
|
1 |
+
---
|
2 |
+
license: other
|
3 |
+
---
|
4 |
# AIDO.RNA-1.6B
|
5 |
|
6 |
AIDO.RNA-1.6B is a general-purpose RNA foundation model with 1.6 billion parameters, trained on 42 million non-coding RNA sequences at single-nucleotide resolution. It achieves state-of-the-art performance on a comprehensive set of tasks, including RNA secondary structure prediction, mRNA-related tasks, RNA function prediction, and RNA inverse folding. After domain adaptation, AIDO.RNA excels in modeling protein-level tasks, highlighting its potential to leverage the central dogma for enhancing biomolecular representations. For more detailed information, please refer to [our paper](https://www.biorxiv.org/content/10.1101/2024.11.28.625345v1).
|
|
|
101 |
year = {2024},
|
102 |
booktitle = {NeurIPS 2024 Workshop on AI for New Drug Modalities},
|
103 |
}
|
104 |
+
```
|